Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica

Journal of the National Cancer Institute

Volumn 92, Issue 6, 2000, Pages 464-474

  Herrero, Rolando ^a,h   Hildesheim, Allan ^c   Bratti, Conception ^d   Sherman, Mark E ^c   Hutchinson, Martha ^e   Morales, Jorge ^d   Balmaceda, Ileana ^d   Greenberg, Mitchell D ^f   Alfaro, Mario ^d   Burk, Robert D ^g   Wacholder, Sholom ^c   Plummer, Martyn ^b   Schiffman, Mark ^c  

^a Ministry of Health   (Costa Rica)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c NATIONAL CANCER INSTITUTE   (United States)

^d CAJA COSTARRICENSE DE SEGURO SOCIAL   (Costa Rica)

^e BROWN UNIVERSITY   (United States)

^f Omnia Corporation   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h Proyecto Epidemiologico Guanacaste   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COSTA RICA; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX TUMOR; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 0034654151     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.6.464     Document Type: Article

References (47)

1. Pisani P, Parkin DM, Munoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in 1995. Cancer Epidemiol Biomarkers Prev 1997;6:387-400.
2. IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans. Vol. 64. Human papillomaviruses. Lyon (France): International Agency for Research on Cancer; 1995.
3. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8.
4. Melken PW, Hopman E, van den Brule AJ, Risse EK, van Diest PJ, Bleker OP, et al. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent, Int J Cancer 1993;53:919-23.
5. Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, Dehovitz JA, et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Trans Dis 1996;23: 333-41.
6. Wright TC, Kurman RJ. A critical review of the morphologic classification systems of preinvasive lesions of the cervix: the scientific basis for shifting the paradigm. Papillomavirus Rep 1994;5:175-82.
7. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
8. Herrero R, Schiffman MH, Bratti C, Hildesheim A, Balmaceda I, Sherman M. et al. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica 1997;1:362-75.
9. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. National Cancer Institute workshop. JAMA 1989;262:931-4.
10. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Report of the 1991 workshop. Am J Surg Pathol 1992;16:914-6.
11. Schiffman MH, Kiviat NB, Burk RD, Shah KV, Daniel RW, Lewis R, et al. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol 1995;33:545-50.
12. Tachezy R, Van Ranst MA, Cruz Y, Burk RD. Analysis of short novel human papillomavirus sequences. Biochem Res Commun 1994;204:820-7.
13. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
14. Jiang G, Qu W, Ruan H, Burk RD. Elimination of false positive signals in enhanced chemiluminescence (ECL) detection of amplified HPV DNA from clinical samples. Biotechniques 1995;19:566-8.
15. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/ GP6+ primer systems. J Clin Microbiol 1997;35:1304-10.
16. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
17. Schatzkin A, Freedman LS, Schiffman MH, Dawsey SM. Validation of intermediate end points in cancer research. J Natl Cancer Inst 1990;82: 1746-52.
18. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985;122:904-14.
19. Horvitz DG. Thompson, DJ. A generalization of sampling without replacement from a finite universe. J Am Stat Assoc 1952;47:663-85.
20. th Berkeley Symposium, vol 1. Berkeley and Los Angeles (CA): Univ California Press; 1967. p. 221-33.
21. White H. Maximum likelihood estimation of misspecified models. Econometrica 1982;50:1-25.
22. Sherman ME, Schiffman MH, Herrero R, Kelly D, Bratti C, Mango L, et al. Performance of a semiautomated Papanicolaou smear screening system. Cancer (Cancer Cytopathol) 1998;84:273-80.
23. Hutchinson ML, Zahniser DJ, Sherman ME, Herrero R, Alfaro M, Bratti MC, et al. Utility of liquid-based cytology for cervical cancer screening: results of a population-based study conducted in a high cervical cancer incidence region of Costa Rica. Cancer Cytopathol. 1999;87:48-55.
24. Schneider DL, Herrero R, Bratti C, Greenberg MD, Hildesheim A, Sherman ME, et al. Cervicography screening for cervical cancer among 8460 women in a high-risk population. Am J Obstet Gynecol 1999;180:290-8.
25. Munm N, Kato I, Bosch FX, Eluf-Neto J, de Sanjose S, Gili M, et al. Risk factors for HPV DNA detection in middle-aged women. Sex Trans Dis 1996;23:504-10.
26. Bosch FX, Munoz N, de San Jose S, Navarro C, Moreo P, Ascunce N, et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/ carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993;2:415-22.
27. Munoz N, Bosch FX, de San Jose S, Tafur L, Izarzugaza I, Gili M, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992;52:743-9.
28. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999;91:226-35.
29. Franco EL, Villa LL, Ruiz A, Costa MC. Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. J Infect Dis 1995;172:756-63.
30. Kjær SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev 1997;6:799-805.
31. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
32. Chauoki N, Bosch FX, Munoz N, Meijer CJ, El Gueddari B, El Ghazi A, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998;75:546-54.
33. Ponten J, Adami HO, Bergstrom R, Dillner J. Friberg LG, Gustafsson L, et al. Strategies for global control of cervical cancer. Int J Cancer 1995;60: 1-26.
34. Park TW, Richart RM, Sun, XW, Wright TC Jr. Association between human papillomavirus type and clonal status of cervical squamous intraepithelial lesions. J Natl Cancer Inst 1996;88:355-8.
35. Torroella-Kouri M, Morsberger S, Carrillo A, Mohar A, Meneses A, Ibarra M, et al. HPV prevalence among Mexican women with neoplastic and normal cervixes. Gynecol Oncol 1998;70:115-20.
36. Matsukura T, Sugase M. Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathologic lesions. Int J Cancer 1995;61:13-22.
37. Kalantari M, Karlsen F, Johansson B, Sigurjonsson T, Warleby B, Hagmar B. Human papillomavirus findings in relation to cervical intraepithelial neoplasia grade. Human Pathol 1997;28:899-904.
38. Ho GY, Kadish AS, Burk RD, Basu J, Palan PR, Mikhail M, Romney SL. HPV 16 and cigarette smoking as risk factors for high-grade cervical intraepithelial neoplasia. Int J Cancer 1998;78:281-5.
39. Huang S, Afonina I, Miller BA, Beckman AM. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer 1997;70:408-11.
40. Lin QQ, Yu SZ, Qu W, Cruz Y, Burk RD. Human papillomavirus types 52 and 58 [letter]. Int J Cancer 1998;75:484-5.
41. Surges RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, et al. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 1996;88:1361-8.
42. Lombard I, Vincent-Salomon A, Validire P, Zafrani B, de la Rochefordiere A, Clough K, et al. Human papillomavirus genotype as a major determinant of the course of cervical cancer. J Clin Oncol 1998;16:2613-9.
43. Viladiu P, Bosch FX, Castelsague X, Munoz N, Escriba JM, Hamsikova E, et al. Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer. J Clin Oncol 1997;15:610-9.
44. van Ranst MA, Tachezy R, Delius H, Burk RD. Taxonomy of human papillomaviruses. Papillomavirus Rep 1993;4:61-5.
45. Chichareon S, Herrero R, Munoz N, Bosch FX, Jacobs MV, Deacon J, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998;90:50-7.
46. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
47. Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, et al. HPV DNA testing for cervical cancer screening: results from the 8,500 randomly selected women in a high-risk province of Costa Rica. JAMA 2000;283:87-93.